| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8651793 | The American Journal of the Medical Sciences | 2018 | 18 Pages |
Abstract
Although there were no differences in the primary outcomes, the shorter LOS in the GDMT group may be clinically significant. The fact that most patients with ESRD and HFrEF were not receiving GDMT is a finding that requires further evaluation.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
B. Tate PharmD, Benjamin T. MS, PharmD, Jagannath MD, Michael PharmD, Lydia PharmD, Joanna Q. PharmD,